IL23A and psoriasis: IL-23 blockade reduces Th17/Tc17 cell frequency but does not fully normalize all inflammatory mediators, indicating that psoriasis involves complex, multifactorial networks, including IL-25 and prostaglandin E (PGE) signaling (55, 92).